Great-West Lifeco (TSE:GWO – Get Free Report) was upgraded by equities researchers at Scotiabank from a “hold” rating to a “strong-buy” rating in a research report issued on Monday,Zacks.com reports.
Several other analysts also recently weighed in on GWO. Royal Bank of Canada boosted their price target on Great-West Lifeco from C$47.00 to C$51.00 in a research note on Friday, November 8th. CIBC upped their price target on Great-West Lifeco from C$55.00 to C$56.00 in a report on Thursday, January 30th. Jefferies Financial Group upped their price target on Great-West Lifeco from C$42.00 to C$48.00 and gave the stock a “hold” rating in a report on Wednesday, October 16th. Finally, Barclays upped their price target on Great-West Lifeco from C$45.00 to C$46.00 in a report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of C$47.88.
View Our Latest Research Report on GWO
Great-West Lifeco Trading Down 0.3 %
Great-West Lifeco (TSE:GWO – Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported C$1.14 earnings per share for the quarter, topping the consensus estimate of C$1.08 by C$0.06. Great-West Lifeco had a return on equity of 13.21% and a net margin of 11.32%. During the same quarter in the prior year, the business posted $1.00 EPS. As a group, equities research analysts anticipate that Great-West Lifeco will post 4.4525194 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, Director Charles Donald Harvey Henaire sold 26,400 shares of the firm’s stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of C$49.50, for a total transaction of C$1,306,800.00. Also, Director Paul Mahon sold 146,826 shares of the firm’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of C$49.88, for a total value of C$7,323,842.39. Over the last three months, insiders sold 174,613 shares of company stock worth $8,697,880. Company insiders own 70.70% of the company’s stock.
About Great-West Lifeco
Great-West Lifeco Inc engages in the life and health insurance, retirement and investment services, asset management, and reinsurance businesses in Canada, the United States, and Europe. The company offers life, accidental death and dismemberment, disability, critical illness, health and dental protection, and creditor insurance products; and retirement and wealth savings, income and annuity products, and other specialty products to individuals, families, businesses, and organizations.
Further Reading
- Five stocks we like better than Great-West Lifeco
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Election Stocks: How Elections Affect the Stock Market
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Great-West Lifeco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Great-West Lifeco and related companies with MarketBeat.com's FREE daily email newsletter.